Showing results (91-100 of 158) with videos related to
Sort By:
Pageof 16
Drug Design, Development and Therapy|January 20, 2021
Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed ConditionsMeng-Na Wang, Hai-Tao Yu, Ya-Qian Li, et al.Drug Design, Development and Therapy|July 21, 2022
Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney DiseaseChengxiao Fu, Qi Pei, Wu Liang, et al.Asian Journal of Andrology|September 15, 2017
PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: evidence from patients in Northwestern ChinaKai-Jie Wu, Xin-Qi Pei, Ge Tian, et al.CPT: Pharmacometrics & Systems Pharmacology|June 19, 2026
Polymyxin B Intravenous Administration Strategy Guided by Minimum Inhibitory Concentration in Critically Ill Patients With Pulmonary Infection: Insights From PBPK ModelingShengnan Zhang, Nan Yang, Ruwei Yang, et al.Psychopharmacology|January 22, 2004
Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brainThomas J R Beveridge, Annis O Mechan, Marie Sprakes, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorderAmanda J Law, Qi Pei, Mary Walker, et al.The AAPS Journal|December 20, 2024
Pharmacokinetic-pharmacodynamic Modelling of NH600001 in Healthy Subjects and Patients Undergoing GastroscopyYaxin Liu, Yun Kuang, Jie Huang, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 1, 2013
Development and validation of an LC-MS/MS method for the determination of tolvaptan in human plasma and its application to a pharmacokinetic studyQi Pei, Bikui Zhang, Hongyi Tan, et al.The AAPS Journal|July 12, 2024
Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK ModelingRuwei Yang, Yaqi Lin, Kaifeng Chen, et al.Investigational New Drugs|June 15, 2020
First-in-human, phase I single-ascending-dose study of the safety, pharmacokinetics, and relative bioavailability of selatinib, a dual EGFR-ErbB2 inhibitor in healthy subjectsMeng-Na Wang, Yun Kuang, Li-Ying Gong, et al.Pageof 16